Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Melanoma 4Neoplasms 2Leukemia, Myeloid, Acute 2Breast Neoplasms 2Sepsis 1Sarcoma 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Pathologic Complete Response 1Neutropenia 1Neuroblastoma 1Neoplasm Metastasis 1Multiple Myeloma 1Malignant mesenchymal tumor 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Diseases 1Graft vs Host Disease 1Gliosarcoma 1Glioblastoma 1Fever 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

liposomal amphotericin B 2Vancomycin 2Cefepime 2trametinib 1pegfilgrastim 1dabrafenib 1ceftobiprole medocaril 1Tazobactam 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Levofloxacin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Filgrastim 1Ciprofloxacin 1Caspofungin 1Bevacizumab 1Anti-Bacterial Agents 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Fever × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT00001338 2008-03-04

A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
65 enrolled
Breast

Breast Neoplasms, Fever, Hematologic Diseases, Neutropenia, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡